Gene expression variations in microsatellite stable and unstable colon cancer cells

Journal of Surgical Research

Volumn 174, Issue 1, 2012, Pages 1-6

  Duldulao, Marjun P ^a   Lee, Wendy ^a   Le, Maithao ^a   Chen, Zhenbin ^a   Li, Wenyan ^a   Wang, Jinhui ^a   Gao, Harry ^a   Li, Haiquing ^a   Kim, Joseph ^a   Garcia Aguilar, Julio ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

5 fluorouracil; colon cancer; DNA damage genes; DNA repair genes; gene expression; microsatellite stable; microsatellite unstable; Solexa; ultra high throughput sequencing

Indexed keywords

FLUOROURACIL;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL STRAIN HCT116; CELL STRAIN HT29; COLON CANCER; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION; GENE OVEREXPRESSION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL;

COLONIC NEOPLASMS; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION PROFILING; GENOTYPE; HCT116 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HT29 CELLS; HUMANS; MICROSATELLITE INSTABILITY;

EID: 84859109888     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.06.016     Document Type: Article

References (44)

1. C.R. Boland, S.N. Thibodeau, and S.R. Hamilton National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248
2. S.W. Choi, K.J. Lee, and Y.A. Bae Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival Clin Cancer Res 8 2002 2311
3. A. de la Chapelle, and H. Hampel Clinical relevance of microsatellite instability in colorectal cancer J Clin Oncol 28 2010 3380
4. D.S. Dunican, P. McWilliam, and O. Tighe Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization Oncogene 21 2002 3253
5. A. Duval, and R. Hamelin Genetic instability in human mismatch repair deficient cancers Ann Genet 45 2002 71
6. A. Hemminki, J.P. Mecklin, and H. Järvinen Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy Gastroenterology 119 2000 921
7. H. Kim, S.W. Nam, and H. Rhee Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas Oncogene 23 2004 6218
8. K. Ng, and D. Schrag Microsatellite instability and adjuvant fluorouracil chemotherapy: A mismatch? J Clin Oncol 28 2010 3207
9. C. Ribic, D.J. Sargent, and M. Moore Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247
10. D.J. Sargent, S. Marsoni, and G. Monges Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol 28 2010 3219
11. E. Vilar, and S.B. Gruber Microsatellite instability in colorectal cancer-The stable evidence Nat Rev Clin Oncol 7 2010 153
12. Y. Ionov, M.A. Peinado, and S. Malkhosyan Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis Nature 363 1993 558
13. D. Shibata, M.A. Peinado, and Y. Ionov Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation Nat Genet 6 1994 273
14. B. Gustavsson, C. Kaiser, and G. Carlsson Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes Int J Cancer 124 2009 1220
15. S.T. Kim, J. Lee, and S.H. Park Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy Cancer Chemother Pharmacol 66 2010 659
16. A. Tajima, M.T. Hess, and B.L. Cabrera The mismatch repair complex hMutS-alpha recognizes 5-fluorouracil-modified DNA: Implications for chemosensitivity and resistance Gastroenterology 127 2004 1678
17. S. Popat, R. Hubner, and R.S. Houlston Systematic review of microsatellite instability and colorectal cancer prognosis J Clin Oncol 23 2005 609
18. C. Agaton, P. Unneberg, and M. Sievertzon Gene expression analysis by signature pyrosequencing Gene 289 2002 31
19. C.D. Armour, J.C. Castle, and R. Chen Digital transcriptome profiling using selective hexamer priming for cDNA synthesis Nat Methods 6 2009 647
20. X. Chen, H. Xu, and P. Yuan Integration of external signaling pathways with the core transcriptional network in embryonic stem cells Cell 133 2008 1106
21. D.Y. Chiang, G. Getz, and D.B. Jaffe High-resolution mapping of copy-number alterations with massively parallel sequencing Nat Methods 6 2009 99
22. S. Fox, S. Filichkin, and T.C. Mockler Applications of ultra-high-throughput sequencing Methods Mol Biol 553 2009 79
23. J.C. Marioni, C.E. Mason, and S.M. Mane RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays Genome Res 18 2008 1509
24. A. Mortazavi, B.A. Williams, and K. McCue Mapping and quantifying mammalian transcriptomes by RNA-Seq Nat Methods 5 2008 621
25. P.A. Hoen, Y. Ariyurek, and H.H. Thygesen Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms Nucleic Acids Res 36 2008 e141
26. P.K. Wall, J. Leebens-Mack, and A.S. Chanderbali Comparison of next generation sequencing technologies for transcriptome characterization BMC Genomics 10 2009 347
27. D. Zhou, M.S. Rao, and R. Walker Massively parallel signature sequencing Methods Mol Biol 331 2006 285
28. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3, 2004.
29. N. Papadopoulos, N.C. Nicolaides, and Y.F. Wei Mutation of a mutL homolog in hereditary colon cancer Science 263 1994 1559
30. S.S. David, V.L. O'Shea, and S. Kundu Base-excision repair of oxidative DNA damage Nature 447 2007 941
31. J.H.J. Hoeijmakers Genome maintenance mechanisms for preventing cancer Nature 411 2001 366
32. S.P. Jackson, and J. Bartek The DNA-damage response in human biology and disease Nature 461 2009 1071
33. C. Miquel, S. Jacob, and S. Grandjouan Frequent alteration of DNA damage signaling and repair pathways in human colorectal cancers with microsatellite instability Oncogene 26 2007 5919
34. R. Scully, S. Ganesan, and K. Vlasakova Genetic analysis of BRCA1 function in a defined tumor cell line Mol Cells 4 1999 1093
35. E. Halapi, and H. Hakonarson Advances in the development of genetic markers for the diagnosis of disease and drug response Expert Rev Mol Diagn 2 2002 411
36. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-fluorouracil: Mechanisms of action and clinical strategies Nat Rev Cancer 3 2003 330
37. L. Pare, E. Marcuello, and A. Altes Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy Br J Cancer 99 2008 1050
38. D. Theile, S. Grebhardt, and W.E. Haefeli Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy Biochem Pharmacol 78 2009 1366
39. S. Popat, R. Wort, and R.S. Houlston Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: Implications for chemoresistance BMC Cancer 6 2006 150
40. R. Ravizza, R. Molteni, and M.B. Gariboldi Effect of HIF-1 modulation on the response of two-and three-dimensional cultures of human colon cancer cells to 5-fluorouracil Eur J Cancer 45 2009 890
41. D. Cao, and G. Pizzorno Uridine phosphorylase: An important enzyme in pyrimidine metabolism and fluoropyrimidine activation Drugs Today (Barc) 40 2004 431
42. Y. Im, H.K. Shin, and H. Kim Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1 Mol Cells 28 2009 119
43. M. Liu, D. Cao, and R. Russell Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorylitic activity in selected human tumors Cancer Res 58 1998 5418
44. L. Wan, D. Cao, and J. Zeng Modulation of uridine phosphorylase gene expression by tumor necrosis factor-α enhances the antiproliferative activity of the capecitabine intermediate 5′-deoxy-5-fluorouridine in breast cancer cells Mol Pharmacol 69 2006 1389